project id: TCGA-STAD; case submitter id: TCGA-IN-A6RN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.58; rna integrity number: 8.6; age at index: 72; days to birth: -26409; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 26409; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 594.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 150.0; sample id: eb45018e-c444-4cfd-9d44-74c9c640a140; sample submitter id: TCGA-IN-A6RN-01A; portion id: 9b30f301-e30d-4478-a20c-f940a1a8271d; portion submitter id: TCGA-IN-A6RN-01A-12; slide id: 98dc19a8-8dfe-4a4d-ba9d-fd942ce98c5e; slide submitter id: TCGA-IN-A6RN-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 75.0; section location: TOP;